Nanomedicine uses particles designed to target specific problems such as tumours, and are able to remain in the body for long periods. In the future, nanosized materials may be used by many technological platforms and will provide exciting opportunities to revolutionise the diagnosis and treatment of diseases.
Marco Siccardi, University of Liverpool is a Senior Lecturer in Pharmacology. He is interested in the clarification of the biological mechanisms underpining pharmacological processes. His research is based on experimental pharmacological methods to optimise future therapies.